Drug Shortage Report for VORICONAZOLE FOR INJECTION
| Report ID | 271611 |
| Drug Identification Number | 02493829 |
| Brand name | VORICONAZOLE FOR INJECTION |
| Common or Proper name | VORICONAZOLE FOR INJECTION |
| Company Name | FRESENIUS KABI CANADA LTD |
| Market Status | MARKETED |
| Active Ingredient(s) | VORICONAZOLE |
| Strength(s) | 200MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | 200 mg |
| ATC code | J02AC |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2025-11-11 |
| Actual start date | |
| Estimated end date | 2025-12-07 |
| Actual end date | 2025-11-14 |
| Shortage status | Resolved |
| Updated date | 2025-11-15 |
| Company comments | Fresenius Kabi Canada regrets to advise that due to release delays, we will be encountering a supply interruption. |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 165 GALAXY BLVD, SUITE 100 TORONTO, ONTARIO CANADA M9W 0C8 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v4 | 2025-11-15 | French | Compare |
| v3 | 2025-11-15 | English | Compare |
| v2 | 2025-11-11 | French | Compare |
| v1 | 2025-11-11 | English | Compare |
Showing 1 to 4 of 4